Recombinetics

About:

Recombinetics targets biomedical and regenerative medicine, opening vast new opportunities to improve and extend human life.

Website: https://recombinetics.com/

Twitter/X: Recombinetics

Top Investors: Grant Newlin

Description:

Recombinetics is a developer of gene editing technologies to improve human health through advanced disease models and regenerative medicine. Its gene-editing technologies manipulate deoxyribonucleic acid (DNA) samples to add and activate genes to solve problems and also offer gene repair and gene editing tools that enable biomedical research, livestock productivity, animal agriculture, and livestock vertical markets to modify animal genomes accurately and efficiently.